Inozyme Pharma To Present Recently Announced Data From Phase 1/2 Trials Of INZ-701 In Adults With ENPP1 Deficiency And ABCC6 Deficiency (PXE) At Upcom...
BOSTON, May 23, 2024 (GLOBE NEWSWIRE) --
Stay updated with breaking news from Rare Bone. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BOSTON, May 23, 2024 (GLOBE NEWSWIRE) --
It's not all jank and bugs! - Let's get this out of the way: The technical state of Pokémon Scarlet and Violet is pretty ...
Amolyt Pharma Amolyt Pharma to Present Preliminary Phase 1 Data on AZP-3601 for Hypoparathyroidism and Additional Preclinical Data on AZP-3404 at ENDO 2021 Amolyt Pharma to Present Preliminary Phase 1 Data on AZP-3601 for Hypoparathyroidism and Additional Preclinical Data on AZP-3404 at ENDO 2021 Four abstracts accepted as poster presentations for the Endocrine Society’s Annual Meeting LYON, France and NEWTON, Mass., March 16, 2021 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specializing in developing therapeutic peptides for rare endocrine and metabolic diseases, today announced ...
(0) Four abstracts accepted as poster presentations for the Endocrine Society's Annual Meeting LYON, France and NEWTON, Mass., March 16, 2021 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specializing in developing therapeutic peptides for rare endocrine and metabolic diseases, today announced that it will be presenting four abstracts at the Endocrine Society's Annual Meeting, ENDO 2021, being held virtually from March 20-23, 2021. Amolyt will present preliminary data from its Phase 1 clinical trial evaluating AZP-3601, a parathyroid hormone analog specifically designed for the treatm...
The Voice and America’s Got Talent are any indication, there are many extremely talented people out there who could become huge successes if presented with the right opportunity. This is no less the case in science, with thousands of extremely bright individuals quietly toiling away in their mentors’ labs as they await the chance to establish research programs of their own. Fortunately, initiatives like the NIH’s Lasker Clinical Research Scholars Program exist to boost promising young researchers on to the next stage of their careers. Every year, the Lasker program allows a small grou...